Phytoestrogens inhibit human 17β-hydroxysteroid dehydrogenase type 5

被引:127
|
作者
Krazeisen, A [1 ]
Breitling, R [1 ]
Möller, G [1 ]
Adamski, J [1 ]
机构
[1] GSF, Natl Res Ctr Environm & Hlth, Inst Expt Genet, Genome Anal Ctr, D-85764 Neuherberg, Germany
关键词
hydroxysteroid dehydrogenase; phytoestrogens; flavonoids; 18 beta-glycyrrhetinic acid;
D O I
10.1016/S0303-7207(00)00422-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The 17 beta -hydroxysteroid dehydrogenase type 5 (17 beta -HSD 5) is involved in estrogen and androgen metabolism. In our study we tested the influence of environmental hormones, such as phytoestrogens (flavonoids, coumarins, coumestans), on reductive and oxidative 17 beta -HSD activity of the human 17 beta -hydroxysteroid dehydrogenase type 5 (17 beta -HSD 5). These dietary substances were shown to be potent inhibitors of aromatase, different 17 beta -HSDs and seem to play an important rule in delay of development of hormone dependent cancers. Our studies show that reductive and oxidative activity of the enzyme are inhibited by many dietary compounds, especially zearalenone. coumestrol, quercetin and biochanin A. Among the group of flavones inhibitor potency is growing with increasing number of hydroxylations. We suggest that these substances are bound to the hydrophilic cofactor-binding pocket of the enzyme. An interesting inhibition pattern is observed for 18 beta -glycyrrhetinic acid, which has no influence on the oxidative but only on the reductive reaction. This indicates that this substrate binds to pH- and cofactor-depending sites at the active center of the enzyme. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 50 条
  • [21] Benzothiazole derivatives as novel inhibitors of human 11β-hydroxysteroid dehydrogenase type 1
    Su, XD
    Vicker, N
    Ganeshapillai, D
    Smith, A
    Purohit, A
    Reed, MJ
    Potter, BVL
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) : 214 - 217
  • [22] Synthesis of a dansyl-labeled inhibitor of 17β-hydroxysteroid dehydrogenase type 3 for optical imaging
    Kenmogne, Lucie Carolle
    Maltais, Rene
    Poirier, Donald
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (09) : 2179 - 2183
  • [23] Dose-response effects of phytoestrogens on the activity and expression of 3β-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells
    Lacey, M
    Bohday, J
    Fonseka, SMR
    Ullah, AI
    Whitehead, SA
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 96 (3-4): : 279 - 286
  • [24] Differential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system
    Park, Aubrey L.
    Lin, Hsueh-Kung
    Yang, Qing
    Sing, Chor Wing
    Fan, Michael
    Mapstone, Timothy B.
    Gross, Naina L.
    Gumerlock, Mary K.
    Martin, Michael D.
    Rabb, Craig H.
    Fung, Kar-Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2010, 3 (08): : 743 - 754
  • [25] Estrone and estradiol C-16 derivatives as inhibitors of type 1 17β-hydroxysteroid dehydrogenase
    Poirier, D
    Chang, H
    Azzi, A
    Boivin, RP
    Lin, SX
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) : 236 - 238
  • [26] New inhibitors of fungal 17β-hydroxysteroid dehydrogenase based on the [1,5]-benzodiazepine scaffold
    Zivec, Matej
    Sova, Matej
    Brunskole, Mojca
    Lenarsic, Roman
    Rizner, Tea Lanisnik
    Gobec, Stanislav
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2007, 22 (01) : 29 - 36
  • [27] Steroidal lactones as inhibitors of 17β-hydroxysteroid dehydrogenase type 5: Chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities
    Bydal, Patrick
    Luu-The, Van
    Labrie, Fernand
    Poirier, Donald
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (02) : 632 - 644
  • [28] Inhibition of 17β-hydroxysteroid dehydrogenase (17β-HSD) by imidazole-based compounds
    Olusanjo, Moniola S.
    Shahid, Imran
    Owen, Caroline P.
    Ahmed, Sabbir
    LETTERS IN DRUG DESIGN & DISCOVERY, 2008, 5 (01) : 48 - 51
  • [29] Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of γ-aminobutyric acid type A receptors
    He, XY
    Wegiel, J
    Yang, YZ
    Pullarkat, R
    Schulz, H
    Yang, SY
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 229 (1-2) : 111 - 117
  • [30] Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Su, Xiangdong
    Halem, Heather A.
    Thomas, Mark P.
    Moutrille, Cecile
    Culler, Michael D.
    Vicker, Nigel
    Potter, Barry V. L.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (21) : 6394 - 6402